CASI Pharmaceuticals, Inc (DE) SC 13G and SC 13G/A reports

Location
9620 Medical Center Dr, Ste 300, Rockville, MD
State of incorporation
DE
Fiscal year end
December 31
Data updated at
7/19/2024, 08:55 AM
Form type Sec Links Description Filing date Reporting date
SC 13G/A Report Feb 9, 2023
SC 13G/A Report Feb 1, 2023
SC 13G/A Report CONSONANCE CAPITAL MANAGEMENT LP Feb 14, 2022
SC 13G/A Report Feb 14, 2022
SC 13G Report CONSONANCE CAPITAL MANAGEMENT LP Feb 17, 2021
SC 13G Report CONSONANCE CAPITAL MANAGEMENT LP Feb 16, 2021
SC 13G Report Feb 12, 2021
SC 13G/A Report SCHEDULE 13G/A Feb 19, 2020
SC 13G/A Report SC 13G/A Feb 6, 2019
SC 13G Report SC 13G Feb 6, 2019
SC 13G/A Report AMENDMENT NO. 1 Oct 11, 2018
SC 13G Report SC 13G Dec 1, 2017
SC 13G/A Report SC 13G/A Mar 3, 2017
SC 13G Report SCHEDULE 13G Mar 21, 2016
SC 13G/A Report SABBY 13G-A ENMD 01.08.14 Jan 8, 2014
SC 13G Report SABBY 13G ENMD 03.06.13 Mar 6, 2013
SC 13G/A Report Feb 14, 2011
SC 13G Report Feb 11, 2010